{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T21:44:09Z","timestamp":1792532649113,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key R&D Program in Xinjiang Uygur Autonomous Region","award":["2022B03019-4"],"award-info":[{"award-number":["2022B03019-4"]}]},{"name":"Scientific Research and Innovation Team Project of Xinjiang Medical University","award":["XYD-2024C09"],"award-info":[{"award-number":["XYD-2024C09"]}]},{"name":"2022 Tianchi Young Talent Doctoral Program","award":["2022TCYCGWJ"],"award-info":[{"award-number":["2022TCYCGWJ"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-026-05476-1","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T16:13:08Z","timestamp":1782576788000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Pan-cancer prioritization of CCDC69 reveals an immune-enriched and therapeutically sensitive breast cancer phenotype"],"prefix":"10.1007","volume":"17","author":[{"given":"Yi","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinghao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruonan","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy Yue","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenlu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zehao","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"key":"5476_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"5476_CR2","first-page":"477","volume":"74","author":"AN Giaquinto","year":"2024","unstructured":"Giaquinto AN, Sung H, Newman LA, Freedman RA, Smith RA, Star J, Jemal A, Siegel RL. Breast cancer statistics 2024. CA Cancer J Clin. 2024;74:477\u201395.","journal-title":"CA Cancer J Clin"},{"key":"5476_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/s41571-021-00565-2","volume":"19","author":"G Bianchini","year":"2022","unstructured":"Bianchini G, De Angelis C, Licata L, Gianni L. Treatment landscape of triple-negative breast cancer - expanded options, evolving needs. Nat Rev Clin Oncol. 2022;19:91\u2013113.","journal-title":"Nat Rev Clin Oncol"},{"key":"5476_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/s41523-022-00468-0","volume":"8","author":"P Zagami","year":"2022","unstructured":"Zagami P, Carey LA. Triple negative breast cancer: Pitfalls and progress. NPJ Breast Cancer. 2022;8:95.","journal-title":"NPJ Breast Cancer"},{"key":"5476_CR5","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMoa2409932","volume":"391","author":"P Schmid","year":"2024","unstructured":"Schmid P, Cortes J, Dent R, McArthur H, Pusztai L, K\u00fcmmel S, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Im SA, Untch M, Fasching PA, Mouret-Reynier MA, Foukakis T, Ferreira M, Cardoso F, Zhou X, Karantza V, Tryfonidis K, Aktan G. O\u2019Shaughnessy, Overall Survival with Pembrolizumab in Early-Stage Triple-Negative Breast Cancer. N Engl J Med. 2024;391:1981\u201391.","journal-title":"N Engl J Med"},{"key":"5476_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1056\/NEJMoa2202809","volume":"387","author":"J Cortes","year":"2022","unstructured":"Cortes J, Rugo HS, Cescon DW, Im SA, Yusof MM, Gallardo C, Lipatov O, Barrios CH, Perez-Garcia J, Iwata H, Masuda N, Torregroza Otero M, Gokmen E, Loi S, Guo Z, Zhou X, Karantza V, Pan W, Schmid P. Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer. N Engl J Med. 2022;387:217\u201326.","journal-title":"N Engl J Med"},{"key":"5476_CR7","doi-asserted-by":"publisher","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","volume":"56","author":"I Mellman","year":"2023","unstructured":"Mellman I, Chen DS, Powles T, Turley SJ. The cancer-immunity cycle: Indication, genotype, and immunotype. Immunity. 2023;56:2188\u2013205.","journal-title":"Immunity"},{"key":"5476_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1038\/s41416-022-02119-4","volume":"128","author":"K Brummel","year":"2023","unstructured":"Brummel K, Eerkens AL, de Bruyn M, Nijman HW. Tumour-infiltrating lymphocytes: from prognosis to treatment selection. Br J Cancer. 2023;128:451\u20138.","journal-title":"Br J Cancer"},{"key":"5476_CR9","doi-asserted-by":"publisher","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","volume":"375","author":"TN Schumacher","year":"2022","unstructured":"Schumacher TN, Thommen DS. Tertiary lymphoid structures in cancer. Science. 2022;375:eabf9419.","journal-title":"Science"},{"key":"5476_CR10","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1200\/JCO.2018.78.2276","volume":"37","author":"PA Ott","year":"2019","unstructured":"Ott PA, Bang YJ, Piha-Paul SA, Razak ARA, Bennouna J, Soria JC, Rugo HS, Cohen RB, O\u2019Neil BH, Mehnert JM, Lopez J, Doi T, van Brummelen EMJ, Cristescu R, Yang P, Emancipator K, Stein K, Ayers M, Joe AK, Lunceford JK. T-Cell-Inflamed Gene-Expression Profile, Programmed Death Ligand 1 Expression, and Tumor Mutational Burden Predict Efficacy in Patients Treated With Pembrolizumab Across 20 Cancers: KEYNOTE-028. J Clin Oncol. 2019;37:318\u201327.","journal-title":"J Clin Oncol"},{"key":"5476_CR11","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1038\/s41416-022-01743-4","volume":"126","author":"H Li","year":"2022","unstructured":"Li H, van der Merwe PA, Sivakumar S. Biomarkers of response to PD-1 pathway blockade. Br J Cancer. 2022;126:1663\u201375.","journal-title":"Br J Cancer"},{"key":"5476_CR12","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.cell.2018.02.052","volume":"173","author":"J Liu","year":"2018","unstructured":"Liu J, Lichtenberg T, Hoadley KA, Poisson LM, Lazar AJ, Cherniack AD, Kovatich AJ, Benz CC, Levine DA, Lee AV, Omberg L, Wolf DM, Shriver CD, Thorsson V, Hu H. An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics. Cell. 2018;173:400\u201316.e411.","journal-title":"Cell"},{"key":"5476_CR13","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1126\/science.aaz1776","volume":"369","author":"The GTEx","year":"2020","unstructured":"The GTEx. Consortium atlas of genetic regulatory effects across human tissues. Science. 2020;369:1318\u201330.","journal-title":"Science"},{"key":"5476_CR14","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A, Thennavan A, Wang C, Torpy JR, Bartonicek N, Wang T, Larsson L, Kaczorowski D, Weisenfeld NI, Uytingco CR, Chew JG, Bent ZW, Chan CL, Gnanasambandapillai V, Dutertre CA, Gluch L, Hui MN, Beith J, Parker A, Robbins E, Segara D, Cooper C, Mak C, Chan B, Warrier S, Ginhoux F, Millar E, Powell JE, Williams SR, Liu XS, O\u2019Toole S, Lim E, Lundeberg J, Perou CM, Swarbrick A. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53:1334\u201347.","journal-title":"Nat Genet"},{"key":"5476_CR15","doi-asserted-by":"publisher","first-page":"8353","DOI":"10.1038\/s41467-023-43458-x","volume":"14","author":"A Janesick","year":"2023","unstructured":"Janesick A, Shelansky R, Gottscho AD, Wagner F, Williams SR, Rouault M, Beliakoff G, Morrison CA, Oliveira MF, Sicherman JT, Kohlway A, Abousoud J, Drennon TY, Mohabbat SH, Taylor SEB. High resolution mapping of the tumor microenvironment using integrated single-cell, spatial and in situ analysis. Nat Commun. 2023;14:8353.","journal-title":"Nat Commun"},{"key":"5476_CR16","doi-asserted-by":"publisher","first-page":"101511","DOI":"10.1016\/j.xcrm.2024.101511","volume":"5","author":"L Xu","year":"2024","unstructured":"Xu L, Saunders K, Huang SP, Knutsdottir H, Martinez-Algarin K, Terrazas I, Chen K, McArthur HM, Mau\u00e9s J, Hodgdon C, Reddy SM, Roussos Torres ET, Xu L, Chan IS. A comprehensive single-cell breast tumor atlas defines epithelial and immune heterogeneity and interactions predicting anti-PD-1 therapy response. Cell Rep Med. 2024;5:101511.","journal-title":"Cell Rep Med"},{"key":"5476_CR17","doi-asserted-by":"publisher","first-page":"3348","DOI":"10.1038\/s41467-025-58511-0","volume":"16","author":"X Wang","year":"2025","unstructured":"Wang X, Wang Z, Liao Q, Yuan P, Mei J, Zhang Y, Wu C, Kang X, Zheng S, Yang C, Liu J, Shang Q, Li J, Wang B, Li L, Liu H, Hu W, Dong Z, Zhao J, Wang L, Liu T, Den Y, Wang C, Han L, Chen Q, Yang H, Xu X, He J, Yue Z, Sun N, Fang X, Ying J. Spatially resolved atlas of breast cancer uncovers intercellular machinery of venular niche governing lymphocyte extravasation. Nat Commun. 2025;16:3348.","journal-title":"Nat Commun"},{"key":"5476_CR18","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cell.2016.06.017","volume":"166","author":"F van Iorio","year":"2016","unstructured":"Iorio F, Knijnenburg TA, Vis DJ, Bignell GR, Menden MP, Schubert M, Aben N, Gon\u00e7alves E, Barthorpe S, Lightfoot H, Cokelaer T, Greninger P, van Dyk E, Chang H, de Silva H, Heyn H, Deng X, Egan RK, Liu Q, Mironenko T, Mitropoulos X, Richardson L, Wang J, Zhang T, Moran S, Sayols S, Soleimani M, Tamborero D, Lopez-Bigas N, Ross-Macdonald P, Esteller M, Gray NS, Haber DA, Stratton MR, Benes CH, Wessels LFA, Saez-Rodriguez J, McDermott U, Garnett MJ. A landscape of pharmacogenomic interactions in cancer. Cell. 2016;166:740\u201354.","journal-title":"Cell"},{"key":"5476_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nchembio.1986","volume":"12","author":"MG Rees","year":"2016","unstructured":"Rees MG, Seashore-Ludlow B, Cheah JH, Adams DJ, Price EV, Gill S, Javaid S, Coletti ME, Jones VL, Bodycombe NE, Soule CK, Alexander B, Li A, Montgomery P, Kotz JD, Hon CS, Munoz B, Liefeld T, Dan\u010d\u00edk V, Haber DA, Clish CB, Bittker JA, Palmer M, Wagner BK, Clemons PA, Shamji AF, Schreiber SL. Correlating chemical sensitivity and basal gene expression reveals mechanism of action. Nat Chem Biol. 2016;12:109\u201316.","journal-title":"Nat Chem Biol"},{"issue":"6","key":"5476_CR20","doi-asserted-by":"publisher","first-page":"3448","DOI":"10.1002\/tox.24205","volume":"39","author":"C Jiang","year":"2024","unstructured":"Jiang C, Zhang S, Jiang L, et al. Precision unveiled: Synergistic genomic landscapes in breast cancer-Integrating single-cell analysis and decoding drug toxicity for elite prognostication and tailored therapeutics. Environ Toxicol. 2024;39(6):3448\u201372.","journal-title":"Environ Toxicol"},{"key":"5476_CR21","doi-asserted-by":"publisher","first-page":"30401","DOI":"10.1038\/s41598-024-81022-9","volume":"14","author":"D Fesquet","year":"2024","unstructured":"Fesquet D, Rabeharivelo G, van Dijk J, Prigent C, Morin N, Rouquier S. CCDC69 maintains genome integrity by regulating KIF2C\/MCAK depolymerase activity and the stability of the chromosomal passenger complex. Sci Rep. 2024;14:30401.","journal-title":"Sci Rep"},{"key":"5476_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13048-019-0479-3","volume":"12","author":"L Cui","year":"2019","unstructured":"Cui L, Zhou F, Chen C, Wang CC. Overexpression of CCDC69 activates p14(ARF)\/MDM2\/p53 pathway and confers cisplatin sensitivity. J Ovarian Res. 2019;12:4.","journal-title":"J Ovarian Res"},{"key":"5476_CR23","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1186\/s12885-023-11411-2","volume":"23","author":"Z Wang","year":"2023","unstructured":"Wang Z, Ren H, Zhu G, Zhang L, Cao H, Chen B. High expression of CCDC69 is correlated with immunotherapy response and protective effects on breast cancer. BMC Cancer. 2023;23:974.","journal-title":"BMC Cancer"},{"issue":"43","key":"5476_CR24","doi-asserted-by":"publisher","first-page":"e08190","DOI":"10.1002\/advs.202508190","volume":"12","author":"P Ding","year":"2025","unstructured":"Ding P, Yang J, Chen S, et al. Interpretable Multimodal Fusion Model Enhances Postoperative Recurrence Prediction in Gastric Cancer. Adv Sci (Weinh). 2025;12(43):e08190.","journal-title":"Adv Sci (Weinh)"},{"key":"5476_CR25","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.ccell.2021.04.014","volume":"39","author":"A Bagaev","year":"2021","unstructured":"Bagaev A, Kotlov N, Nomie K, Svekolkin V, Gafurov A, Isaeva O, Osokin N, Kozlov I, Frenkel F, Gancharova O, Almog N, Tsiper M, Ataullakhanov R, Fowler N. Conserved pan-cancer microenvironment subtypes predict response to immunotherapy. Cancer Cell. 2021;39:845\u2013e865847.","journal-title":"Cancer Cell"},{"key":"5476_CR26","doi-asserted-by":"publisher","first-page":"100293","DOI":"10.1016\/j.patter.2021.100293","volume":"2","author":"\u00d3 Lapuente-Santana","year":"2021","unstructured":"Lapuente-Santana \u00d3, van Genderen M, Hilbers PAJ, Finotello F, Eduati F. Interpretable systems biomarkers predict response to immune-checkpoint inhibitors. Patterns (N Y). 2021;2:100293.","journal-title":"Patterns (N Y)"},{"key":"5476_CR27","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","volume":"24","author":"MA Harris","year":"2024","unstructured":"Harris MA, Savas P, Virassamy B, O\u2019Malley MMR, Kay J, Mueller SN, Mackay LK, Salgado R, Loi S. Towards targeting the breast cancer immune microenvironment. Nat Rev Cancer. 2024;24:554\u201377.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"5476_CR28","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1007\/s12672-025-03074-1","volume":"16","author":"H Ma","year":"2025","unstructured":"Ma H, Liu J, Jin H, Zhang M, Liang Q, Guo Z. Comprehensive characterization of NK cell-related genes in cutaneous melanoma identified a novel prognostic signature for predicting the prognosis, immunotherapy, and chemotherapy efficacy. Discov Oncol. 2025;16(1):1243.","journal-title":"Discov Oncol"},{"key":"5476_CR29","doi-asserted-by":"publisher","first-page":"1192777","DOI":"10.3389\/fphar.2023.1192777","volume":"14","author":"K Yuan","year":"2023","unstructured":"Yuan K, Zhao S, Ye B, et al. A novel T-cell exhaustion-related feature can accurately predict the prognosis of OC patients. Front Pharmacol. 2023;14:1192777.","journal-title":"Front Pharmacol"},{"key":"5476_CR30","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, Kami\u0144ska B, Huelsken J, Omberg L, Gevaert O, Colaprico A, Czerwi\u0144ska P, Mazurek S, Mishra L, Heyn H, Krasnitz A, Godwin AK, Lazar AJ, Stuart JM, Hoadley KA, Laird PW, Noushmehr H, Wiznerowicz M. Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell. 2018;173:338\u201354.e315.","journal-title":"Cell"},{"key":"5476_CR31","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ccell.2018.03.007","volume":"33","author":"AM Taylor","year":"2018","unstructured":"Taylor AM, Shih J, Ha G, Gao GF, Zhang X, Berger AC, Schumacher SE, Wang C, Hu H, Liu J, Lazar AJ, Cherniack AD, Beroukhim R, Meyerson M. Genomic and Functional Approaches to Understanding Cancer Aneuploidy. Cancer Cell. 2018;33:676\u2013e689673.","journal-title":"Cancer Cell"},{"key":"5476_CR32","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41523-024-00671-1","volume":"10","author":"JW Pan","year":"2024","unstructured":"Pan JW, Tan ZC, Ng PS, Zabidi MMA, Nur Fatin P, Teo JY, Hasan SN, Islam T, Teoh LY, Jamaris S, See MH, Yip CH, Rajadurai P, Looi LM, Taib NAM, Rueda OM, Caldas C, Chin SF, Lim J, Teo SH. Gene expression signature for predicting homologous recombination deficiency in triple-negative breast cancer. NPJ Breast Cancer. 2024;10:60.","journal-title":"NPJ Breast Cancer"},{"key":"5476_CR33","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41523-025-00873-1","volume":"12","author":"A Sanjari Moghaddam","year":"2025","unstructured":"Sanjari Moghaddam A, Lu KY, Nasrollahi E, Oji L, Homeniuk A, Amosu O, Chelysheva D, Brufsky AM. Biomarker prediction of immunotherapy response in breast cancer: from single markers to multi-omics integration. NPJ Breast Cancer. 2025;12:10.","journal-title":"NPJ Breast Cancer"},{"issue":"47","key":"5476_CR34","doi-asserted-by":"publisher","first-page":"e2406276","DOI":"10.1002\/advs.202406276","volume":"11","author":"P Ding","year":"2024","unstructured":"Ding P, Wu J, Wu H, et al. Transcriptomics-Based Liquid Biopsy for Early Detection of Recurrence in Locally Advanced Gastric Cancer. Adv Sci (Weinh). 2024;11(47):e2406276.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"5476_CR35","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/pro6.1241","volume":"8","author":"X Xu","year":"2024","unstructured":"Xu X, Yin Y, Zhang L, Wang D, Zhou Y, Li Q. Research progress of cardiotoxicity caused by radiotherapy in breast cancer. Precis Radiat Oncol. 2024;8(3):153\u20138.","journal-title":"Precis Radiat Oncol"},{"issue":"19","key":"5476_CR36","doi-asserted-by":"publisher","first-page":"10305","DOI":"10.18632\/aging.205077","volume":"15","author":"P Zhang","year":"2023","unstructured":"Zhang P, Zhang H, Tang J, et al. The integrated single-cell analysis developed an immunogenic cell death signature to predict lung adenocarcinoma prognosis and immunotherapy. Aging. 2023;15(19):10305\u201329.","journal-title":"Aging"},{"issue":"1","key":"5476_CR37","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/pro6.1225","volume":"8","author":"K Meng","year":"2024","unstructured":"Meng K, Lu H. Clinical application of high-LET radiotherapy combined with immunotherapy in malignant tumors. Precis Radiat Oncol. 2024;8(1):42\u20136.","journal-title":"Precis Radiat Oncol"},{"issue":"1","key":"5476_CR38","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1007\/s12672-024-01627-4","volume":"15","author":"M Zhang","year":"2024","unstructured":"Zhang M, Liu J, Zhang F, Liang Q, Guo Z. Comprehensive characterization of neddylation related genes in cutaneous melanoma identified a novel prognostic signature for treatment outcomes, immune landscape. Discov Oncol. 2024;15(1):722.","journal-title":"Discov Oncol"},{"key":"5476_CR39","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1038\/s41591-024-03398-5","volume":"31","author":"SK Yoo","year":"2025","unstructured":"Yoo SK, Fitzgerald CW, Cho BA, Fitzgerald BG, Han C, Koh ES, Pandey A, Sfreddo H, Crowley F, Korostin MR, Debnath N, Leyfman Y, Valero C, Lee M, Vos JL, Lee AS, Zhao K, Lam S, Olumuyide E, Kuo F, Wilson EA, Hamon P, Hennequin C, Saffern M, Vuong L, Hakimi AA, Brown B, Merad M, Gnjatic S, Bhardwaj N, Galsky MD, Schadt EE, Samstein RM, Marron TU, G\u00f6nen M, Morris LGT, Chowell D. Prediction of checkpoint inhibitor immunotherapy efficacy for cancer using routine blood tests and clinical data. Nat Med. 2025;31:869\u201380.","journal-title":"Nat Med"},{"key":"5476_CR40","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1038\/s41467-025-56827-5","volume":"16","author":"F Carli","year":"2025","unstructured":"Carli F, Di Chiaro P, Morelli M, Arora C, Bisceglia L, De Oliveira Rosa N, Cortesi A, Franceschi S, Lessi F, Di Stefano AL, Santonocito OS, Pasqualetti F, Aretini P, Miglionico P, Diaferia GR, Giannotti F, Li\u00f2 P, Duran-Frigola M, Mazzanti CM, Natoli G, Raimondi F. Learning and actioning general principles of cancer cell drug sensitivity. Nat Commun. 2025;16:1654.","journal-title":"Nat Commun"},{"issue":"1","key":"5476_CR41","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/pro6.1221","volume":"8","author":"K Takeda","year":"2024","unstructured":"Takeda K, Umezawa R, Yamamoto T, et al. Lymphocytopenia following adjuvant radiotherapy for breast cancer. Precis Radiat Oncol. 2024;8(1):22\u20139.","journal-title":"Precis Radiat Oncol"},{"issue":"Pt 1","key":"5476_CR42","doi-asserted-by":"publisher","first-page":"147098","DOI":"10.1016\/j.ijbiomac.2025.147098","volume":"323","author":"J Liu","year":"2025","unstructured":"Liu J, Wang YT, Zeng LL, Chen CL. Lactate-related genes signature as a novel prognostic landscape in laryngeal squamous cell carcinoma: insights from 156 machine learning algorithms and in vitro validation. Int J Biol Macromol. 2025;323(Pt 1):147098.","journal-title":"Int J Biol Macromol"},{"issue":"1","key":"5476_CR43","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13046-024-03098-5","volume":"43","author":"P Ding","year":"2024","unstructured":"Ding P, Wu H, Wu J, et al. Transcriptomics-based liquid biopsy panel for early non-invasive identification of peritoneal recurrence and micrometastasis in locally advanced gastric cancer. J Exp Clin Cancer Res. 2024;43(1):181.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-026-05476-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05476-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-026-05476-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:02:45Z","timestamp":1787151765000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-026-05476-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5476"],"URL":"https:\/\/doi.org\/10.1007\/s12672-026-05476-1","relation":{},"ISSN":["2730-6011"],"issn-type":[{"value":"2730-6011","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"3 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1209"}}